| | 873857-62-6 Basic information More.. |
| Product Name: | FidaxoMicin | | Synonyms: | FidaxoMicin;3-(((6-Deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-b-D-mannopyranosyl)oxy)-methyl)-12(R)-[(6-deoxy-5-C-methyl-4-O-(2-methyl-1-oxopropyl)-b-D-lyxo-hexopyranosyl)oxy]-11(S)-ethyl-8(S)-hydroxy-18(S)-(1(R)-hydroxyethyl)-9,13,15-trimethyloxacyclooctadeca-3,5,9,13,15-pentaene-2-one;OPT-80;PAR-101;R-Tiacumicin B;Oxacyclooctadeca-3,5,9,13,15-pentaen-2-one, 3-[[[6-deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-β-D-mannopyranosyl]oxy]methyl]-12-[[6-deoxy-5-C-methyl-4-O-(2-methyl-1-oxopropyl)-β-D-lyxo-hexopyranosyl]oxy]-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-, (3E,5E,8S,9E,11S,12R,13E,15E,18S)-;3-(((6-Deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-b-D-mannopyranosyl)oxy)-methyl)-12(R)-[(6-deoxy-5-C-methyl-4-O-(2-methyl-1-oxopropyl)-b-D-lyxo-hexopyranosyl)oxy]-11(S)-eth;Fidaxomicin
R-Tiacumicin B | | CAS: | 873857-62-6 | | MF: | C52H74Cl2O18 | | MW: | 1058.04 | | EINECS: | | | Mol File: | 873857-62-6.mol |  |
Use
Fidaxomicin and its primary metabolite op-1118, which results from hydrolysis of the isobutyryl ester, are narrowspectrum antibacterial agents with activity against gram-positive aerobic and anaerobic organisms, but not against gram-negative organisms. fidaxomicin (opt-80) was approved for the treatment of clostridium difficile-associated diarrhea (cdad), joining metronidazole and vancomycin as drugs recommended for treatment of c. difficile infections (cdi).
- Fidaxomicin
-
- US $0.00 / kg
- 2024-04-12
- CAS:873857-62-6
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 2000ton
- Fidaxomicin
-
- US $0.00-0.00 / g
- 2023-11-01
- CAS:873857-62-6
- Min. Order: 1g
- Purity: 99.0% min
- Supply Ability: 100kgs
- FidaxoMicin
-
- US $55.00 / g
- 2021-11-25
- CAS:873857-62-6
- Min. Order: 100g
- Purity: 99.99%
- Supply Ability: 5ton/Month
|
|
873857-62-6
Recommend Suppliers |
|